Tuberculosis Unmasked: The Hidden Infection, the Warning Signs, and the Road to Recovery

(Note: For PDF File Swipe To The End Of Article)

Category: Respiratory Medicine, Infectious Diseases, Medical Education

1. Introduction: The Disease That Can Hide in the Body

Tuberculosis, commonly known as TB, is one of the world's oldest recognized infectious diseases—and it remains a major public health challenge today. Despite major advances in medical science, diagnostic technology, and antibiotic treatment, tuberculosis continues to affect millions of people worldwide.

The disease is caused primarily by a bacterium called Mycobacterium tuberculosis. It most commonly affects the lungs, but it can also involve the lymph nodes, bones, kidneys, brain, spine, abdomen, and other organs.

One of the most important features of tuberculosis is that infection does not always lead to immediate illness. In some people, the immune system controls the bacteria, allowing them to remain in the body without causing symptoms. This is known as latent tuberculosis infection, or inactive TB. In other people, the bacteria multiply and cause active tuberculosis disease.

Tuberculosis can develop gradually. A person may experience a persistent cough, tiredness, fever, night sweats, loss of appetite, or unexplained weight loss for weeks before seeking medical attention. Because these symptoms can resemble other illnesses, diagnosis may be delayed.

Without appropriate treatment, active tuberculosis can cause serious organ damage and may become life-threatening. However, the disease is preventable and curable in most cases when it is diagnosed correctly and treated with an effective, complete regimen.

Understanding tuberculosis requires more than memorizing its symptoms. It involves learning how the bacteria spread, how the immune system responds, why some people become ill while others do not, how modern tests detect infection, and why completing treatment is essential.

This article explores tuberculosis in detail, from its biology and clinical presentation to diagnosis, treatment, drug resistance, prevention, and the social challenges faced by people living with the disease.

2. What Is Tuberculosis?

Tuberculosis is an infectious disease caused mainly by Mycobacterium tuberculosis, a slow-growing bacterium that can survive within the human body.

The lungs are the most frequently affected organs. When tuberculosis involves the lungs, it is called pulmonary tuberculosis. When it affects organs outside the lungs, it is called extrapulmonary tuberculosis.

The disease does not affect everyone in the same way. Some people have infection without symptoms, while others develop active disease soon after infection or years later.

Important definitions

Tuberculosis infection: The bacteria have entered the body and triggered an immune response. Infection does not necessarily mean that the person has active disease.

Latent tuberculosis infection (LTBI): The person has TB infection but no evidence of active tuberculosis disease. They do not have symptoms attributable to active TB and cannot transmit TB through ordinary respiratory spread while the infection remains inactive.

Active tuberculosis disease: The bacteria are multiplying and causing illness or tissue damage. Pulmonary or laryngeal TB may be infectious and can spread through the air.

Pulmonary tuberculosis: TB involving the lungs.

Extrapulmonary tuberculosis: TB affecting organs or tissues outside the lungs, such as lymph nodes, bones, kidneys, or the central nervous system.

Drug-resistant tuberculosis: TB caused by bacteria resistant to one or more medicines used to treat the disease.

These distinctions matter because testing, treatment, infectiousness, and follow-up differ according to the type of tuberculosis.

3. A Brief History of Tuberculosis

Tuberculosis has affected human populations for thousands of years. Historical evidence of TB-like disease has been identified in ancient human remains, and written descriptions of wasting illnesses may include cases that were likely tuberculosis.

Before modern antibiotics, tuberculosis was frequently fatal. It was often called consumption because affected individuals could experience progressive weight loss, weakness, and wasting.

During the nineteenth century, tuberculosis became a major public health concern in crowded industrial cities. Poor housing, inadequate nutrition, limited ventilation, and lack of effective treatment contributed to its spread.

A major scientific breakthrough occurred in 1882 when Robert Koch identified the bacterium responsible for tuberculosis. This discovery helped establish TB as an infectious disease rather than a condition caused simply by heredity, poor character, or other misconceptions.

Later developments transformed TB care:

• Improved laboratory methods helped identify the bacteria.
• Chest radiography supported the evaluation of lung disease.
• Antibiotics made effective treatment possible.
• The Bacille Calmette–Guérin (BCG) vaccine became an important tool for preventing severe childhood TB.
• Modern molecular tests began detecting TB bacteria and certain drug-resistance patterns more rapidly.
• Newer treatment regimens have expanded options for selected forms of drug-resistant disease.

Yet tuberculosis remains closely linked to poverty, overcrowding, undernutrition, limited access to healthcare, and other social determinants of health. Medical advances alone cannot eliminate the disease without effective public health systems and equitable access to diagnosis and treatment.

4. The Bacterium Behind Tuberculosis

Mycobacterium tuberculosis belongs to a group of bacteria known as mycobacteria.

These organisms have a distinctive, lipid-rich cell wall containing mycolic acids. This structure contributes to their unusual staining properties and helps protect them from some environmental and chemical stresses.

Why is the bacterium difficult to eliminate?

Several features make tuberculosis challenging to treat.

Slow growth: The bacteria multiply more slowly than many common disease-causing bacteria. As a result, treatment usually takes months rather than a few days.

Persistence in tissues: TB bacteria can survive in the body for prolonged periods, particularly when the immune system contains them without completely eliminating them.

Different bacterial populations: In active disease, some bacteria may be rapidly multiplying, while others may be in less active metabolic states. Different medicines act differently against these populations.

Ability to develop drug resistance: If treatment is inadequate, interrupted, or based on medicines that are ineffective against the organism, resistant bacteria may survive and multiply.

Complex interaction with the immune system: The body may contain TB bacteria within organized immune structures, but these defenses do not always eradicate the infection.

These features explain why tuberculosis requires carefully selected combinations of medicines, consistent treatment, and appropriate follow-up.

5. How Tuberculosis Spreads

Tuberculosis usually spreads through the air.

When a person with infectious pulmonary or laryngeal TB coughs, speaks, sings, or otherwise releases airborne particles containing TB bacteria, another person may inhale those particles.

The risk depends on several factors, including the infectiousness of the source patient, the duration and closeness of exposure, ventilation, and the susceptibility of the exposed person.

Situations associated with increased transmission risk

• Spending prolonged periods in the same poorly ventilated room as someone with infectious TB.
• Living in a crowded household with a person who has untreated infectious pulmonary TB.
• Working in a healthcare or other setting where infectious TB exposure occurs without adequate precautions.
• Having repeated close contact with someone whose infectious disease has not yet been diagnosed or effectively treated.

TB transmission is especially concerning in indoor environments with poor airflow.

How tuberculosis usually does not spread

Tuberculosis is not ordinarily transmitted through:

• Shaking hands.
• Hugging.
• Sharing a handshake or brief social greeting.
• Sharing food or drinks.
• Touching toilet seats.
• Using the same clothing or bed linen.
• Ordinary contact with surfaces.

This is important because fear of casual contact can lead to unnecessary isolation and discrimination.

Can every person with TB transmit it?

No. People with latent TB infection do not spread TB bacteria to others.

People with active TB outside the lungs are often not infectious through the respiratory route, although some forms of disease and certain procedures require specific precautions. Pulmonary or laryngeal TB is particularly important because it can produce infectious airborne particles.

The infectiousness of an individual patient depends on clinical and microbiological factors, the treatment being taken, and the response to treatment.

6. What Happens After TB Bacteria Enter the Body?

The first stage often occurs when inhaled particles reach the small air sacs of the lungs, called alveoli.

Immune cells known as macrophages attempt to engulf the bacteria. However, M. tuberculosis can survive within some macrophages and interfere with normal immune defenses.

The body then activates a broader immune response involving several types of white blood cells.

In many people, the immune response limits bacterial multiplication and organizes infected cells into structures called granulomas. These structures help contain the infection.

However, containment is not always complete.

Some bacteria may persist, and the infection may later become active if immune control weakens. In other cases, the immune system may fail to contain the infection from the beginning, allowing disease to develop.

The role of granulomas

Granulomas are organized collections of immune cells that form around persistent infectious agents or other substances the body cannot easily eliminate.

In tuberculosis, granulomas can help restrict bacterial spread. They may contain macrophages, lymphocytes, and other immune cells.

The center of some TB granulomas develops a cheese-like appearance called caseous necrosis. This feature can be seen in tissue specimens, although it is not exclusive to tuberculosis.

Granulomas are part of the body's defense, but they can also contribute to tissue damage. If disease progresses, affected tissue may break down, and cavities can develop in the lungs.

7. Latent TB Infection Versus Active Tuberculosis

The distinction between latent infection and active disease is central to understanding tuberculosis.

Feature	Latent TB infection	Active TB disease
Bacteria in the body	Present but controlled by the immune system	Multiplying and causing disease
Symptoms	Absent	May include cough, fever, weight loss, or organ-specific symptoms
Ability to spread TB	No respiratory transmission from latent infection	Pulmonary or laryngeal disease may be infectious
Chest X-ray	Often normal, though not always in every clinical context	May show abnormalities, depending on the disease
TB blood or skin test	Often positive	Often positive, but a negative result does not always exclude disease
Treatment purpose	Prevent progression to active disease	Cure active infection and prevent complications and transmission

A positive TB skin test or blood test does not, by itself, distinguish latent infection from active disease. Additional clinical assessment is needed.

Can latent TB become active?

Yes. Latent TB infection can progress to active disease if the immune system no longer controls the bacteria.

Progression is more likely in certain circumstances, including:

• HIV infection, especially when untreated or advanced.
• Treatment with certain immune-suppressing medicines.
• Organ transplantation.
• Some cancers and cancer treatments.
• Diabetes.
• Severe undernutrition.
• Certain chronic medical conditions.
• Recent infection with TB bacteria.

The risk of progression is often greatest during the first couple of years after infection, but active disease can develop much later.

Preventive treatment can substantially reduce this risk in appropriately selected individuals.

8. Causes and Risk Factors for Tuberculosis Disease

Exposure to TB bacteria does not guarantee infection, and infection does not guarantee active disease. Several factors influence the likelihood of acquiring TB and developing illness.

8.1 Close exposure to infectious TB

Household members and other close contacts of someone with infectious pulmonary TB may have a higher risk of infection.

Contact investigation helps identify people who may need testing, clinical evaluation, or preventive treatment.

8.2 HIV infection

HIV weakens important components of the immune system. This increases the risk that latent TB will progress to active disease and can lead to more severe or unusual presentations.

People living with HIV may also develop extrapulmonary or disseminated TB.

8.3 Diabetes mellitus

Diabetes is associated with an increased risk of developing active TB. Poor glucose control may complicate recovery and increase the likelihood of unfavorable outcomes.

Integrated care for diabetes and tuberculosis is therefore important in areas where both conditions are common.

8.4 Undernutrition

Poor nutritional status can impair immune function and increase vulnerability to infection and disease progression.

TB itself may worsen undernutrition through reduced appetite, increased metabolic demands, and chronic inflammation.

8.5 Smoking and indoor air pollution

Smoking is associated with increased risks of TB infection, active disease, and poor outcomes. Exposure to indoor air pollution may also contribute to respiratory vulnerability.

Avoiding tobacco smoke and improving indoor air quality support general respiratory health.

8.6 Alcohol use and substance-related risks

Heavy alcohol use may increase TB risk through several pathways, including immune effects, undernutrition, and barriers to consistent medical care.

Substance use may also complicate medication adherence and increase the risk of drug interactions or liver injury.

8.7 Crowded housing and poor ventilation

People living or working in crowded, poorly ventilated settings may experience greater exposure to airborne TB particles.

This is a public health issue as much as an individual one. Better housing, ventilation, infection control, and access to diagnosis help reduce transmission.

8.8 Immune-suppressing treatment

Certain medicines, including some biologic therapies and prolonged courses of corticosteroids, can increase the risk of TB reactivation.

Before starting particular immune-suppressing treatments, clinicians may recommend screening for TB infection and treating latent infection when indicated.

8.9 Age

Young children are at particular risk of developing severe forms of TB after infection. Older adults may have a greater likelihood of reactivation or other medical conditions that complicate treatment.

Tuberculosis can occur at any age, however, and age alone cannot determine whether someone has the disease.

9. Types of Tuberculosis

Tuberculosis can be classified according to the site affected, disease activity, and the drug susceptibility of the bacteria.

9.1 Pulmonary tuberculosis

Pulmonary TB affects the lungs and is the most familiar form of the disease.

Symptoms may include persistent cough, sputum production, chest discomfort, fever, night sweats, fatigue, and weight loss.

Some people develop cavities in lung tissue, while others have less obvious imaging findings.

Because pulmonary TB may be infectious, early recognition is important for protecting household members and the wider community.

9.2 Extrapulmonary tuberculosis

Extrapulmonary TB occurs when the bacteria affect organs outside the lungs.

It can develop through spread from the original infection or as part of a more widespread disease process.

Common sites include lymph nodes, pleura, bones, joints, kidneys, the abdomen, and the central nervous system.

Symptoms depend on the affected organ and may be very different from those of pulmonary TB.

9.3 Disseminated tuberculosis

Disseminated TB occurs when the infection spreads to multiple parts of the body.

Miliary tuberculosis is a particular form in which numerous tiny lesions may appear in multiple organs, often because bacteria have spread through the bloodstream.

Disseminated disease can be severe and is more likely in certain immunocompromised patients, although it can occur in others as well.

9.4 Drug-susceptible tuberculosis

Drug-susceptible TB is caused by bacteria that remain susceptible to the key medicines selected for the standard treatment regimen.

It can usually be treated effectively when the diagnosis is accurate and the complete regimen is taken correctly.

9.5 Drug-resistant tuberculosis

Drug-resistant TB occurs when the bacteria are resistant to one or more anti-TB medicines.

Resistance can be present when infection is first acquired or can emerge when treatment does not effectively suppress all the bacteria.

Drug-resistant disease requires specialist assessment, susceptibility testing, and an appropriately selected regimen.

10. Symptoms of Pulmonary Tuberculosis

Pulmonary tuberculosis often develops gradually. Early symptoms may be mild and easy to overlook.

A cough that persists for several weeks should be medically evaluated, especially when accompanied by other symptoms or a history of TB exposure.

10.1 Persistent cough

A persistent cough is one of the most recognized symptoms of pulmonary TB.

The cough may initially be dry and later produce sputum. It can resemble symptoms of other respiratory infections, asthma, chronic lung disease, or other conditions.

A cough lasting three weeks or longer is an important reason to seek medical assessment, particularly in a setting where TB is common. However, people with other warning signs should not wait three weeks before seeking care.

10.2 Coughing up blood

Hemoptysis means coughing up blood or blood-stained sputum.

It can occur when tuberculosis damages blood vessels in affected lung tissue, particularly when cavities or extensive inflammation develop.

Coughing up blood can also occur in other serious conditions. Significant bleeding, breathing difficulty, or chest pain requires urgent medical evaluation.

10.3 Fever

TB may cause a low-grade fever that persists or recurs over time.

Some patients experience more noticeable fever in the evening, but this pattern is not specific to tuberculosis and cannot confirm the diagnosis.

10.4 Night sweats

Some patients experience excessive sweating during sleep, sometimes enough to soak clothing or bedding.

Night sweats have many possible causes, so they must be interpreted alongside the other symptoms and the person's medical history.

10.5 Unexplained weight loss

Weight loss may result from reduced appetite, inflammation, and increased metabolic demands associated with chronic infection.

Unintentional weight loss should be assessed, particularly when accompanied by a persistent cough, fever, or night sweats.

10.6 Loss of appetite

A person with TB may feel less interested in food. Poor appetite can contribute to weakness, nutritional deficiencies, and further weight loss.

10.7 Fatigue and weakness

Chronic infection can cause persistent tiredness, reduced exercise tolerance, and a general feeling of illness.

These symptoms may develop slowly, allowing some individuals to adapt to reduced activity without recognizing the severity of their condition.

10.8 Chest pain and breathlessness

Chest discomfort may occur when TB affects the lungs or the pleura, the membrane surrounding the lungs.

Breathlessness may develop when disease is extensive or when complications such as pleural effusion occur.

Sudden or severe chest pain and significant difficulty breathing require urgent assessment because many conditions can cause these symptoms.

11. Extrapulmonary Tuberculosis: When TB Affects Other Organs

TB can affect nearly any organ. These forms may be more difficult to recognize because their symptoms often resemble other diseases.

11.1 Tuberculous lymphadenitis

TB may cause enlargement of lymph nodes, especially in the neck.

The affected nodes may enlarge gradually and can sometimes become matted together. In some cases, the skin over the node becomes inflamed or the node drains through a sinus.

However, enlarged lymph nodes have many possible causes, including ordinary infections and cancers. Clinical assessment and appropriate sampling are needed.

11.2 Tuberculosis of the pleura

The pleura is the thin membrane surrounding the lungs.

TB pleuritis can cause chest pain that worsens with breathing, fever, cough, and breathlessness. Fluid may collect between the pleural layers, producing a pleural effusion.

Diagnosis may require imaging and analysis of pleural fluid, sometimes alongside other tests.

11.3 Tuberculosis of the spine

Spinal TB, sometimes called Pott disease, can cause persistent back pain, spinal tenderness, and progressive damage to vertebrae.

In severe cases, the infection can cause spinal deformity or compress nerves and the spinal cord.

New limb weakness, difficulty walking, or loss of bladder or bowel control in a person with suspected spinal disease requires urgent evaluation.

11.4 Tuberculosis of the brain and meninges

Tuberculous meningitis occurs when TB affects the membranes surrounding the brain and spinal cord.

Symptoms may include persistent headache, fever, vomiting, confusion, neck stiffness, seizures, or reduced consciousness.

The disease can be life-threatening and requires urgent hospital treatment.

Symptoms may develop gradually, particularly in children, so early recognition is important.

11.5 Genitourinary tuberculosis

TB can affect the kidneys, urinary tract, or reproductive organs.

Possible symptoms include blood in the urine, urinary discomfort, frequent urination, flank pain, or unexplained reproductive problems.

The symptoms depend on the location and extent of disease. Specialized urine testing, imaging, and other investigations may be needed.

11.6 Abdominal tuberculosis

Abdominal TB can involve the intestines, abdominal lymph nodes, or the lining of the abdominal cavity.

Symptoms may include abdominal pain, swelling, fever, loss of appetite, weight loss, diarrhea, constipation, or changes in bowel habits.

Because these symptoms are nonspecific, diagnosis may require imaging, endoscopy, fluid analysis, or tissue sampling.

11.7 Tuberculosis of the bones and joints

Bone and joint TB can cause chronic pain, swelling, stiffness, and reduced movement.

It may affect the spine, hip, knee, or other joints. Early evaluation can help prevent permanent structural damage.

11.8 Tuberculosis of the skin and other tissues

Cutaneous TB is uncommon but can produce persistent skin lesions, ulcers, nodules, or other changes.

Other rare sites include the eyes, adrenal glands, and reproductive organs. Clinical manifestations depend on the tissue involved and the patient's immune status.

12. Tuberculosis in Children

Children can develop TB after exposure to an infectious person, often within their household or close social environment.

Young children are particularly vulnerable to severe disease, including TB meningitis and disseminated tuberculosis.

Symptoms in children

Possible symptoms include:

• Persistent cough.
• Fever.
• Poor weight gain or weight loss.
• Reduced activity.
• Decreased appetite.
• Enlarged lymph nodes.
• Persistent tiredness.
• Symptoms related to extrapulmonary disease.

Symptoms can be subtle. Children may not produce sputum reliably, and microbiological confirmation may be more difficult than in adults.

Why early assessment matters

Young children may progress from infection to disease more rapidly than older children and adults. A child exposed to infectious TB should receive prompt evaluation according to local clinical guidance.

Assessment may include a detailed exposure history, examination, TB infection testing, chest imaging, and age-appropriate microbiological sampling.

The role of BCG vaccination

The BCG vaccine provides important protection against severe childhood forms of TB, particularly TB meningitis and disseminated disease.

Its protection against adult pulmonary TB varies across populations and settings. Vaccination does not guarantee that a person will never become infected or develop active TB.

In countries where TB is common, BCG vaccination is often included in national childhood immunization programs.

13. Tuberculosis During Pregnancy

Tuberculosis can occur during pregnancy and may affect the health of both the pregnant person and the baby if it is not recognized and treated.

Symptoms may be mistaken for ordinary pregnancy-related fatigue or other respiratory conditions. A persistent cough, unexplained fever, weight loss, night sweats, or known exposure warrants medical assessment.

The risks of untreated active TB generally outweigh the risks of appropriately selected treatment. However, drug selection, timing, monitoring, and management of possible complications require specialist care.

Pregnancy also affects decisions about some preventive regimens and other medicines. Patients should not start, stop, or alter anti-TB treatment without professional guidance.

With timely diagnosis, appropriate treatment, and antenatal follow-up, many people with TB can have favorable outcomes.

14. Tuberculosis and HIV

Tuberculosis and HIV are closely linked because HIV weakens the immune system that normally helps control TB infection.

A person living with HIV has a greater risk of developing active TB after infection. TB may also present in less typical ways, including disease outside the lungs.

Important clinical considerations

• People with HIV may need regular assessment for TB symptoms and exposure.
• TB infection testing and preventive treatment may be appropriate under clinical guidance.
• Active TB requires prompt diagnosis and treatment.
• Antiretroviral therapy is an important part of care for people with HIV.
• The timing of HIV treatment during TB treatment depends on clinical factors, including whether the central nervous system is involved.
• Drug interactions must be reviewed carefully.

Integrated management of TB and HIV improves the likelihood that both conditions will be treated effectively.

15. How Is Tuberculosis Diagnosed?

The diagnosis of tuberculosis combines clinical assessment, microbiological testing, imaging, and sometimes tissue sampling.

No single test is appropriate for every patient. The choice depends on symptoms, the suspected site of disease, age, immune status, previous TB treatment, and local testing availability.

15.1 Medical history

A clinician may ask about:

• Duration and nature of the cough.
• Fever, night sweats, and weight loss.
• Coughing up blood.
• Known contact with someone who has TB.
• Previous TB infection or treatment.
• Travel or residence in areas where TB is common.
• HIV status and other immune-related conditions.
• Diabetes and other chronic illnesses.
• Current medicines, including immune-suppressing drugs.

The history helps determine which tests are most appropriate.

15.2 Physical examination

The clinician may assess temperature, respiratory rate, oxygen saturation, body weight, lymph nodes, chest sounds, and other findings.

Examination can provide important clues, but it cannot independently confirm or rule out TB.

15.3 Sputum testing

For suspected pulmonary TB, sputum may be collected for laboratory analysis.

Depending on the local diagnostic pathway, tests may include:

• Smear microscopy.
• Molecular testing.
• Mycobacterial culture.
• Drug susceptibility testing.

Sputum collection should follow healthcare instructions. Some patients need more than one specimen, and the exact approach depends on the diagnostic method and local guidelines.

15.4 Molecular tests

Rapid molecular tests can detect genetic material from TB bacteria and, depending on the assay, identify certain drug-resistance markers.

These tests can provide results more quickly than traditional culture and help clinicians begin appropriate treatment earlier.

However, molecular tests must be interpreted in context, particularly in patients who have previously received TB treatment or when the specimen and clinical findings do not agree.

15.5 Mycobacterial culture

Culture attempts to grow the bacteria from a clinical specimen.

It can provide important evidence of active disease and may allow detailed drug susceptibility testing.

Because M. tuberculosis grows slowly, culture results can take longer than rapid molecular tests. Culture remains an important part of TB diagnosis and resistance assessment.

15.6 Chest X-ray

Chest radiography can reveal abnormalities that support a diagnosis of pulmonary TB.

Possible findings include upper-lung opacities, cavities, enlarged lymph nodes, pleural effusion, or diffuse small nodules.

However, imaging findings are not specific to TB. Other infections, inflammatory conditions, and tumors can produce similar abnormalities.

A normal chest X-ray does not exclude every form of TB, particularly in some immunocompromised patients or those with extrapulmonary disease.

15.7 CT and other imaging

Computed tomography may provide more detailed information about lung abnormalities or complications.

Ultrasound, MRI, and other imaging techniques may be useful when TB is suspected in the abdomen, brain, spine, lymph nodes, or other organs.

The most appropriate imaging study depends on the suspected location and clinical urgency.

15.8 Tissue and fluid sampling

When TB affects a lymph node, pleura, bone, or another organ, a clinician may collect tissue or fluid for testing.

Depending on the site, samples may undergo microscopy, molecular testing, culture, and histopathological examination.

Tissue sampling can be especially important when imaging alone cannot distinguish TB from cancer or other infections.

15.9 Tuberculin skin test

The tuberculin skin test (TST), often called the Mantoux test, involves injecting a small amount of tuberculin under the skin and measuring the resulting induration after the recommended interval.

A positive result may indicate TB infection, but it does not establish active disease.

BCG vaccination and exposure to certain other mycobacteria can affect interpretation.

15.10 Interferon-gamma release assays

Interferon-gamma release assays (IGRAs) are blood tests that measure immune responses to selected TB antigens.

They can help identify TB infection and are generally not affected by prior BCG vaccination in the same way as the skin test.

However, a positive IGRA does not distinguish latent infection from active TB. A negative result does not reliably exclude active disease in every patient, especially when the immune system is weakened or clinical suspicion is high.

15.11 Testing for drug resistance

Drug resistance is a major concern because it can make treatment more complicated.

Testing may identify resistance to rifampicin, isoniazid, and other medicines, depending on the available method.

The results help clinicians select an effective regimen rather than relying on medicines that may not work against the patient's strain.

Key point: A person with symptoms suggestive of TB needs clinical assessment even if an initial test is negative. The diagnosis should be based on the full clinical picture and appropriate follow-up.

16. Diseases That Can Resemble Tuberculosis

Several conditions can cause a persistent cough, fever, weight loss, or abnormal chest imaging.

These include:

• Bacterial pneumonia.
• Lung cancer.
• Chronic obstructive pulmonary disease.
• Bronchiectasis.
• Fungal lung infections.
• Sarcoidosis.
• Other inflammatory lung diseases.
• Certain occupational lung diseases.
• Other chronic infections.

Extrapulmonary TB may also resemble cancer, inflammatory bowel disease, ordinary lymph-node infections, spinal infections, or other organ-specific conditions.

The purpose of diagnostic testing is not simply to look for TB but also to consider alternative explanations and avoid unnecessary or inappropriate treatment.

17. Treatment of Active Tuberculosis

Tuberculosis is usually curable, but successful treatment requires an effective combination of medicines taken for the full prescribed duration.

Treatment is selected according to the site of disease, drug susceptibility, previous treatment, other medical conditions, age, pregnancy status, medication interactions, and national guidelines.

Why are several medicines used together?

Using multiple effective medicines helps kill different bacterial populations and reduces the chance that resistant bacteria will survive.

Taking only one medicine for active TB, or taking an ineffective combination, can allow resistance to develop.

Standard treatment for drug-susceptible TB

For many people with drug-susceptible pulmonary TB, a traditional treatment course lasts about six months.

A commonly used regimen includes an initial phase with four medicines:

• Isoniazid.
• Rifampicin.
• Pyrazinamide.
• Ethambutol.

This is often abbreviated as HRZE.

The initial phase is followed by a continuation phase using selected medicines, commonly isoniazid and rifampicin.

The exact regimen and duration depend on the patient and applicable clinical guidance. Some patients qualify for shorter, approved regimens, while others require longer treatment because of the disease site, complications, resistance, or other clinical factors.

Patients must follow the regimen prescribed by their TB treatment team rather than copying a schedule from an article or another person.

17.1 Isoniazid

Isoniazid is an important anti-TB medicine that interferes with the synthesis of mycolic acids in the bacterial cell wall.

Potential adverse effects include liver injury and peripheral neuropathy.

Clinicians may prescribe pyridoxine (vitamin B6) for selected patients to reduce the risk of neuropathy, particularly when risk factors are present.

17.2 Rifampicin

Rifampicin inhibits bacterial RNA synthesis and is one of the key medicines used in many TB regimens.

It can turn urine, sweat, saliva, or tears an orange-red color. This can be expected, but patients should discuss unexpected symptoms with their healthcare professional.

Rifampicin also interacts with many medicines because it affects drug-metabolizing enzymes and transport systems. Important interactions can involve hormonal contraceptives, anticoagulants, antiretroviral medicines, and other drugs.

17.3 Pyrazinamide

Pyrazinamide helps shorten treatment by acting against certain bacterial populations in the body's tissues.

It can cause liver injury and increase uric acid levels, sometimes contributing to joint pain or gout-like symptoms.

17.4 Ethambutol

Ethambutol interferes with bacterial cell-wall formation.

An important adverse effect is optic toxicity, which may affect vision and color perception. Patients should report visual changes promptly, and appropriate baseline and follow-up monitoring may be required.

Why monitoring matters

Anti-TB medicines can cause adverse effects, but many people complete treatment successfully with appropriate monitoring.

Patients should report symptoms such as yellowing of the eyes or skin, severe nausea, persistent vomiting, marked abdominal pain, unusual bruising, numbness, or changes in vision.

The treatment team may arrange blood tests or other assessments depending on the regimen and individual risk factors.

Patients should not stop all medicines on their own when side effects occur. Prompt clinical advice is important because the team may need to assess the cause and adjust treatment safely.

18. Why Completing TB Treatment Is Essential

TB treatment takes months because the bacteria grow slowly and may persist in different metabolic states within the body.

Symptoms often improve before all the bacteria have been eliminated. Feeling better does not necessarily mean that treatment can safely be stopped.

Incomplete or irregular treatment can lead to:

• Return of the disease.
• Continued transmission.
• Treatment failure.
• Development or selection of drug resistance.
• A need for more complicated and potentially longer treatment.

Adherence can be difficult because patients may need to take several medicines for a prolonged period while managing work, family responsibilities, travel, adverse effects, and financial pressures.

Supportive treatment programs can help patients complete therapy. Depending on the setting, support may include counseling, follow-up visits, reminders, transport assistance, medicine access, or directly observed treatment when appropriate.

The goal is not to blame patients for difficulties but to identify barriers and help them complete an effective course.

Medical Disclaimer

This article is intended for general educational purposes and does not replace professional medical advice, diagnosis, or treatment. A persistent cough, coughing up blood, unexplained weight loss, prolonged fever, or known exposure to TB warrants medical assessment. Severe breathlessness, significant bleeding, confusion, or other severe symptoms require urgent medical care.

Do not start, stop, or change anti-tuberculosis medicines without guidance from a qualified healthcare professional.